Haemorrhagic colitis due to Escherichia coli O103:H2 associated with infliximab therapy in a patient with rheumatoid arthritis
Gespeichert in:
| Veröffentlicht in: | British journal of rheumatology 2002-03, Vol.41 (3), p.355-356 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 356 |
|---|---|
| container_issue | 3 |
| container_start_page | 355 |
| container_title | British journal of rheumatology |
| container_volume | 41 |
| creator | Kirchgatterer, A. Weber, T. Hinterreiter, M. Knoflach, P. Allerberger, F. |
| description | |
| doi_str_mv | 10.1093/rheumatology/41.3.355 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_20203980</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20203980</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-58f83c48c4c9306415c8e9472108cdb6ab7765d29aa3806aec1e3774b2633e043</originalsourceid><addsrcrecordid>eNpdkU1v1DAQhi0EoqXwE0AWB27Z2h7bsbmh0rKgSj0UBOrFchxv45Kst7Yjuhd-Oy67FMRpRjPPOx96EXpJyYISDcdp8PNkSxzj9faY0wUsQIhH6JByyRoCwB4_5IwfoGc53xBCBAX1FB1QqoFrxQ7Rz6X1U0xpsNfBYRfHUELG_exxifg0u8Gn4IZgf7fwBSXwdsmwzTm6YIvv8Y9QBhzWqzHchcl2uFSF3WxrCVu8sSX4ddlBfy4OPbapDOl-03P0ZGXH7F_s4xH6cnb6-WTZnF98-Hjy7rxxnLalEWqlwHHluNNAJKfCKa95yyhRru-k7dpWip5pa0ERab2jHtqWd0wCeMLhCL3Zzd2keDv7XMwUsvPjaNc-ztkwwghoRSr4-j_wJs5pXW8zVAspNWhZIbGDXIo5J78ym1SfT1tDibl3x_zrjuHUgKnuVN2r_fC5m3z_V7W3owLNDgi5-LuHvk3fjWyhFWb57cpcfr3UV_rsk3kPvwAqUZ8O</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>195669396</pqid></control><display><type>article</type><title>Haemorrhagic colitis due to Escherichia coli O103:H2 associated with infliximab therapy in a patient with rheumatoid arthritis</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Kirchgatterer, A. ; Weber, T. ; Hinterreiter, M. ; Knoflach, P. ; Allerberger, F.</creator><creatorcontrib>Kirchgatterer, A. ; Weber, T. ; Hinterreiter, M. ; Knoflach, P. ; Allerberger, F.</creatorcontrib><identifier>ISSN: 1462-0324</identifier><identifier>ISSN: 1460-2172</identifier><identifier>EISSN: 1462-0332</identifier><identifier>EISSN: 1460-2172</identifier><identifier>DOI: 10.1093/rheumatology/41.3.355</identifier><identifier>PMID: 11934982</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Aged ; Antibodies, Monoclonal - therapeutic use ; Antirheumatic Agents - therapeutic use ; Arthritis, Rheumatoid - complications ; Arthritis, Rheumatoid - drug therapy ; Arthritis, Rheumatoid - pathology ; Colitis, Ulcerative - etiology ; Colitis, Ulcerative - microbiology ; Colitis, Ulcerative - pathology ; Escherichia coli ; Escherichia coli - isolation & purification ; Escherichia coli - pathogenicity ; Escherichia coli - physiology ; Escherichia coli Infections - complications ; Escherichia coli Infections - pathology ; Female ; Humans ; Infliximab</subject><ispartof>British journal of rheumatology, 2002-03, Vol.41 (3), p.355-356</ispartof><rights>Copyright Oxford University Press(England) Mar 2002</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-58f83c48c4c9306415c8e9472108cdb6ab7765d29aa3806aec1e3774b2633e043</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11934982$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kirchgatterer, A.</creatorcontrib><creatorcontrib>Weber, T.</creatorcontrib><creatorcontrib>Hinterreiter, M.</creatorcontrib><creatorcontrib>Knoflach, P.</creatorcontrib><creatorcontrib>Allerberger, F.</creatorcontrib><title>Haemorrhagic colitis due to Escherichia coli O103:H2 associated with infliximab therapy in a patient with rheumatoid arthritis</title><title>British journal of rheumatology</title><addtitle>Rheumatology</addtitle><subject>Aged</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Antirheumatic Agents - therapeutic use</subject><subject>Arthritis, Rheumatoid - complications</subject><subject>Arthritis, Rheumatoid - drug therapy</subject><subject>Arthritis, Rheumatoid - pathology</subject><subject>Colitis, Ulcerative - etiology</subject><subject>Colitis, Ulcerative - microbiology</subject><subject>Colitis, Ulcerative - pathology</subject><subject>Escherichia coli</subject><subject>Escherichia coli - isolation & purification</subject><subject>Escherichia coli - pathogenicity</subject><subject>Escherichia coli - physiology</subject><subject>Escherichia coli Infections - complications</subject><subject>Escherichia coli Infections - pathology</subject><subject>Female</subject><subject>Humans</subject><subject>Infliximab</subject><issn>1462-0324</issn><issn>1460-2172</issn><issn>1462-0332</issn><issn>1460-2172</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU1v1DAQhi0EoqXwE0AWB27Z2h7bsbmh0rKgSj0UBOrFchxv45Kst7Yjuhd-Oy67FMRpRjPPOx96EXpJyYISDcdp8PNkSxzj9faY0wUsQIhH6JByyRoCwB4_5IwfoGc53xBCBAX1FB1QqoFrxQ7Rz6X1U0xpsNfBYRfHUELG_exxifg0u8Gn4IZgf7fwBSXwdsmwzTm6YIvv8Y9QBhzWqzHchcl2uFSF3WxrCVu8sSX4ddlBfy4OPbapDOl-03P0ZGXH7F_s4xH6cnb6-WTZnF98-Hjy7rxxnLalEWqlwHHluNNAJKfCKa95yyhRru-k7dpWip5pa0ERab2jHtqWd0wCeMLhCL3Zzd2keDv7XMwUsvPjaNc-ztkwwghoRSr4-j_wJs5pXW8zVAspNWhZIbGDXIo5J78ym1SfT1tDibl3x_zrjuHUgKnuVN2r_fC5m3z_V7W3owLNDgi5-LuHvk3fjWyhFWb57cpcfr3UV_rsk3kPvwAqUZ8O</recordid><startdate>20020301</startdate><enddate>20020301</enddate><creator>Kirchgatterer, A.</creator><creator>Weber, T.</creator><creator>Hinterreiter, M.</creator><creator>Knoflach, P.</creator><creator>Allerberger, F.</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7QL</scope><scope>C1K</scope></search><sort><creationdate>20020301</creationdate><title>Haemorrhagic colitis due to Escherichia coli O103:H2 associated with infliximab therapy in a patient with rheumatoid arthritis</title><author>Kirchgatterer, A. ; Weber, T. ; Hinterreiter, M. ; Knoflach, P. ; Allerberger, F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-58f83c48c4c9306415c8e9472108cdb6ab7765d29aa3806aec1e3774b2633e043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Aged</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Antirheumatic Agents - therapeutic use</topic><topic>Arthritis, Rheumatoid - complications</topic><topic>Arthritis, Rheumatoid - drug therapy</topic><topic>Arthritis, Rheumatoid - pathology</topic><topic>Colitis, Ulcerative - etiology</topic><topic>Colitis, Ulcerative - microbiology</topic><topic>Colitis, Ulcerative - pathology</topic><topic>Escherichia coli</topic><topic>Escherichia coli - isolation & purification</topic><topic>Escherichia coli - pathogenicity</topic><topic>Escherichia coli - physiology</topic><topic>Escherichia coli Infections - complications</topic><topic>Escherichia coli Infections - pathology</topic><topic>Female</topic><topic>Humans</topic><topic>Infliximab</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kirchgatterer, A.</creatorcontrib><creatorcontrib>Weber, T.</creatorcontrib><creatorcontrib>Hinterreiter, M.</creatorcontrib><creatorcontrib>Knoflach, P.</creatorcontrib><creatorcontrib>Allerberger, F.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>British journal of rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kirchgatterer, A.</au><au>Weber, T.</au><au>Hinterreiter, M.</au><au>Knoflach, P.</au><au>Allerberger, F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Haemorrhagic colitis due to Escherichia coli O103:H2 associated with infliximab therapy in a patient with rheumatoid arthritis</atitle><jtitle>British journal of rheumatology</jtitle><addtitle>Rheumatology</addtitle><date>2002-03-01</date><risdate>2002</risdate><volume>41</volume><issue>3</issue><spage>355</spage><epage>356</epage><pages>355-356</pages><issn>1462-0324</issn><issn>1460-2172</issn><eissn>1462-0332</eissn><eissn>1460-2172</eissn><cop>England</cop><pub>Oxford University Press</pub><pmid>11934982</pmid><doi>10.1093/rheumatology/41.3.355</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1462-0324 |
| ispartof | British journal of rheumatology, 2002-03, Vol.41 (3), p.355-356 |
| issn | 1462-0324 1460-2172 1462-0332 1460-2172 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_20203980 |
| source | MEDLINE; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection |
| subjects | Aged Antibodies, Monoclonal - therapeutic use Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - complications Arthritis, Rheumatoid - drug therapy Arthritis, Rheumatoid - pathology Colitis, Ulcerative - etiology Colitis, Ulcerative - microbiology Colitis, Ulcerative - pathology Escherichia coli Escherichia coli - isolation & purification Escherichia coli - pathogenicity Escherichia coli - physiology Escherichia coli Infections - complications Escherichia coli Infections - pathology Female Humans Infliximab |
| title | Haemorrhagic colitis due to Escherichia coli O103:H2 associated with infliximab therapy in a patient with rheumatoid arthritis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T09%3A28%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Haemorrhagic%20colitis%20due%20to%20Escherichia%20coli%20O103:H2%20associated%20with%20infliximab%20therapy%20in%20a%20patient%20with%20rheumatoid%20arthritis&rft.jtitle=British%20journal%20of%20rheumatology&rft.au=Kirchgatterer,%20A.&rft.date=2002-03-01&rft.volume=41&rft.issue=3&rft.spage=355&rft.epage=356&rft.pages=355-356&rft.issn=1462-0324&rft.eissn=1462-0332&rft_id=info:doi/10.1093/rheumatology/41.3.355&rft_dat=%3Cproquest_cross%3E20203980%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=195669396&rft_id=info:pmid/11934982&rfr_iscdi=true |